查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391962

神经再生治疗市场：按神经再生治疗类型、按适应症、按给药方法、按年龄组、按最终用户、按地区

Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, By Indication, By Mode of Administration, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年全球神经再生治疗市场规模为116.7亿美元，预计2030年将达266.1亿美元，2023年至2030年复合年增长率为12.5%。

报告范围 报告详情
基准年 2022年 2023年市场规模 116.7亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 12.50% 2030年市场规模预测 266.1亿美元
图 1. 2023 年神经再生疗法的全球市场占有率（按地区划分）
神经再生治疗市场-IMG1

神经再生是指神经元、轴突、突触、神经胶质细胞等神经组织的再生或修復过程。这个过程对于替换因损伤而受损的组织并确保长期功能恢復至关重要。新的神经元和连结被合成，提供新的资源来取代受损的神经元。神经再生不仅是身体恢復的重要机制，也是维持认知功能的重要机制。它在对抗记忆丧失和老龄化相关异常方面发挥着重要作用。神经再生的药理刺激可以恢復认知功能，提升记忆力和其他认知能力。总之，神经再生是一个重要的生物过程，对于治疗各种神经系统疾病和促进大脑健康具有重要意义。

市场动态：

由于几个关键因素，预计全球神经再生治疗市场在未来几年将显着成长。首先，神经系统疾病（包括中枢和周边神经系统疾病）的盛行率不断增加，对有效和安全的治疗提出了很高的需求。这些疾病可能对患者的生活造成严重影响，因此对神经再生治疗的需求变得极为重要。其次，世界人口高龄化迅速加剧。老年人更容易患神经系统疾病，进一步增加了对这些治疗方法的需求。随着人们寻求改善生活品质的治疗方法，神经再生疗法市场预计将会成长。最后，神经再生领域的研究和开发活动正在迅速增加。科学家和研究人员不断探索新的治疗方法，并在了解如何刺激神经组织修復和再生方面取得突破。这种持续的创新预计将为市场带来新的治疗方法并推动进一步成长。总而言之，高疾病负担、高龄化以及积极的研发正在推动全球神经再生治疗市场向前发展。

例如，2023年2月6日，生物技术公司Biogen Inc.和Sage Therapeutics, Inc.获得美国食品药物管理局（FDA）批准用于治疗重度忧郁症（MDD）和产后忧郁症（PPD）。该公司已收到zuranolone 的新药认证申请（NDA）。 Zuranolone 是一种临床实验药物，正在评估为每日一次、为期 14 天的快速起效口服疗法，用于治疗成人 MDD 和 PPD。

本研究的主要特点

  • 本报告对全球神经再生治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务实绩和策略）介绍了全球神经再生治疗市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 神经再生疗法的全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球神经再生治疗市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 神经系统疾病负担增加
    • 成本高且缺乏熟练的专业人员
    • 对安全有效治疗方法的高需求
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球神经再生治疗市场 - 冠状冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章全球神经再生治疗市场，依神经再生治疗类型，2018-2030

  • 介绍
  • 干细胞疗法
  • 基因治疗
  • 药物治疗
  • 神经刺激疗法
  • 其他的

第六章 2018-2030 年全球神经再生治疗市场（依适应症）

  • 介绍
  • 脊髓损伤
  • 中风
  • 创伤性脑损伤
  • 帕金森氏症
  • 阿兹海默症
  • 多发性硬化症
  • 週边神经损伤
  • 其他的

第七章全球神经再生治疗市场，依给药方法，2018-2030

  • 介绍
  • 口服
  • 注射
  • 埋葬
  • 其他的

第8章全球神经再生治疗市场，依年龄组，2018-2030

  • 介绍
  • 儿童
  • 成人
  • 老年人

第 9 章 全球神经再生治疗市场，依最终使用者划分，2018-2030 年

  • 介绍
  • 医院
  • 专科诊所
  • 研究机构
  • 復健中心
  • 其他的

第十章 全球神经再生治疗市场（按地区），2018-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争形势

  • Biogen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ceregene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Stemedica Cell Technologies, Inc.
  • StemCells Inc.
  • Ever Supreme Bio Technology Co., Ltd.
  • AbbVie

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5837

Global neuroregeneration therapy market size is estimated to be valued at US$ 11.67 Bn in 2023, and is expected to reach US$ 26.61 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 11.67 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.50% 2030 Value Projection: US$ 26.61 Bn
Figure 1. Global Neuroregeneration Therapy Market Share (%),By Region, 2023
Neuroregeneration Therapy Market - IMG1

Neuroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

  • This report provides in-depth analysis of the global neuroregeneration therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

  • By Type of Neuroregeneration Therapy:
    • Stem Cell Therapy
    • Gene Therapy
    • Pharmacological Therapy
    • Neurostimulation Therapy
    • Others
  • By Indication:
    • Spinal Cord Injury
    • Stroke
    • Traumatic Brain Injury
    • Parkinson's Disease
    • Alzheimer's Disease
    • Multiple Sclerosis
    • Peripheral Nerve Injury
    • Others
  • By Mode of Administration:
    • Oral
    • Injectable
    • Implantable
    • Others
  • By Age Group:
    • Pediatric
    • Adult
    • Geriatric
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Research Institutes
    • Rehabilitation Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Biogen Inc.
    • AstraZeneca PLC
    • Pfizer Inc.
    • Novartis International AG
    • Merck & Co., Inc.
    • Sanofi S.A.
    • F.Hoffmann-La Roche Ltd.
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Ceregene Inc.
    • Lineage Cell Therapeutics, Inc.
    • Stemedica Cell Technologies, Inc.
    • StemCells Inc.
    • Ever Supreme Bio Technology Co., Ltd.
    • AbbVie

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type of Neuroregeneration Therapy
    • Market Snippet, By Indication
    • Market Snippet, By Mode of Administration
    • Market Snippet, By Age Group
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing burden of neurological disorders
    • High cost and dearth of skilled professionals
    • High demand for safe and effective therapeutics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Pharmacological Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurostimulation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Indication, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Spinal Cord Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Traumatic Brain Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Bn)
  • Parkinson's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Alzheimer's Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Multiple Sclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030 ,(US$ Bn)
  • Peripheral Nerve Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Mode of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Implantable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Other
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By Age Group, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Rehabilitation Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Neuroregeneration Therapy Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

  • Biogen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca PLC
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Ceregene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Stemedica Cell Technologies, Inc.
  • StemCells Inc.
  • Ever Supreme Bio Technology Co., Ltd.
  • AbbVie
  • Analyst Views

12. Section

  • Research Methodology
  • About us